2) cyclosporine
[英][,saikləu'spɔ:ri:n] [美][,saɪklə'spɔrin, -ɪn, -'spor-]
环孢霉素
1.
Comparison of cyclophosphamide and cyclosporine in the treatment of steroid-resistant idiopathic nephrotic syndrome in children;
环磷酰胺与环孢霉素A治疗儿童激素耐药型肾病综合征临床疗效比较
2.
Assessment of Cyclosporine Concentration in the Blood by Fluorescence Polarizati on Immunoassay;
荧光偏振免疫分析法检测环孢霉素血药浓度
3.
Observation of preventing high-risk corneal graft rejection by cyclosporine A;
环孢霉素A在高危角膜移植免疫排斥应用观察
3) cyclosporin A
环孢霉素A
1.
Proliferative effects of cyclosporin A on cultured human retroocular fibroblast growth;
环孢霉素A对球后成纤维细胞体外增殖的影响
2.
Curative Effect on Chronic Aplastic Anemia by Combination of Companison and Large Dose of Gammaglobulin & Cyclosporin A;
康力龙 丙种球蛋白 环孢霉素A治疗慢性再障贫血
3.
Inhibitory effect of cyclosporin A on growth and collagen synthesis of rat cardiac fibroblasts induced by arginine vasopressin;
环孢霉素A抑制血管升压素诱导的心脏成纤维细胞增殖和胶原合成(英文)
4) cyclosporine A
环孢霉素A
1.
Inhibiting effects of cyclosporine A on proliferation of human retinal pigment epithelium;
环孢霉素A抑制人视网膜色素上皮细胞增生的体外研究
2.
Effects of Cyclosporine A on Proliferation and Collagen I of Unstimulated or Stimulated Vascular Smooth Muscle Cells;
环孢霉素A对静态和刺激状态血管平滑肌细胞增殖和胶原Ⅰ的作用
3.
Cyclosporine A inhibits mitochondrial permeability transition of tubular cells in ischemic acute renal failure rats;
小剂量环孢霉素A抑制大鼠缺血性急性肾衰竭中肾小管上皮细胞线粒体通透性转运
5) calicheamicins
刺孢霉素
1.
Progress in calicheamicins;
刺孢霉素族抗生素的研究进展
6) cyclosporine
[英][,saikləu'spɔ:ri:n] [美][,saɪklə'spɔrin, -ɪn, -'spor-]
环孢霉素A
1.
Lacrimal epithelial cell apoptosis and related gene expression in castrated male rabbits with experimental xerophthalmia and the effect of dropping cyclosporine;
去势雄兔干眼模型泪腺上皮细胞凋亡和相关基因表达及局部环孢霉素A的治疗效果
2.
Application of tacrolimus and cyclosporine A in HBV-carrying renal transplant recipients;
乙型肝炎病毒携带者肾移植术后应用他克莫司和环孢霉素A的临床研究
3.
Both of them were treated with surgical debridement of the ulcer,supratarsal injection of triamcinolone acetonide,topical cyclosporine 0.
5g/L环孢霉素A和0。
补充资料：孢霉素
分子式：
CAS号：
性质：放线菌Streptosporangium pseu-dovulgare PO-357产生的大分子肽类抗生素。由发酵滤液用硫酸铵沉淀法分离纯化制得，为白色粉末，分子量：8500～9000，熔点220～225°(变黑)，旋光度-56°(c=0.5，水)。具有抗革兰阳性细菌活性，并能抑制肉瘤-180、白血病P-388与L-1210细胞。
CAS号：
性质：放线菌Streptosporangium pseu-dovulgare PO-357产生的大分子肽类抗生素。由发酵滤液用硫酸铵沉淀法分离纯化制得，为白色粉末，分子量：8500～9000，熔点220～225°(变黑)，旋光度-56°(c=0.5，水)。具有抗革兰阳性细菌活性，并能抑制肉瘤-180、白血病P-388与L-1210细胞。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条